RPA Is Just the Start: How Insurers Can Develop a Successful Intelligent Process Automation Strategy

whitePaper | August 20, 2021

While finding and creating insights can often feel like luck, there are proven methodologies you can use to ensure you’re seeing regular insight from your on-hand data. Access this short e-book to learn how you can start seeing regular, valuable insight success from you big data and analytics investments.

whitePaper | July 8, 2022

This series of white papers lays out the essential steps you need to take to ensure your business stays at the forefront of an increasingly data-driven and automated world. We cover everything you need to know about growing a data science team, the current trends in machine learning, data visualisation, essential data science tools and technologies, automation, deployment, how to prove value with data science and also give our thoughts on the next ‘big ideas’ that are set to take the world of AI in business by storm.

whitePaper | May 5, 2021

Over the last decade, interest in the field of data science has not only increased enormously, but has also changed and developed considerably. In view of the new technological advances and the constant growth of data, we expect Data Science to continue to develop strongly in 2021. We have identified 7 trends that will be relevant for the coming year.

whitePaper | July 1, 2022

Data is an extremely valuable asset in today’s world. After all, there are entire industries based on it. Because of this, it’s important to evangelize the value of data within your organization.

whitePaper | July 12, 2022

In many ways, 2022 has been an exercise in dealing with the reeling of the Covid-19 pandemic. All over the world, supply chain issues have led to a myriad of challenges for enterprises, leading to deep shifts in how we do business and unraveling many of our assumptions about how society operates.

whitePaper | September 12, 2022

This whitepaper examines clinical trial data contribution policies and the data protection methodologies applied to protect patient privacy. Information published by 29 biopharma sponsors was collected across three data-sharing platforms, collated by sponsor size. Results showed that large sponsor contribution policies can provide helpful benchmarks for medium and smaller sponsors.